Dr Elizabeth Kingsley

Marketing and Scientific Communications

Elizabeth provides scientific support to the business development activities at Retrogenix, working closely with research groups at global pharmaceutical companies to plan projects aiming to identify the specific cell surface targets of antibodies, proteins, small molecules and viruses. She is also responsible for external marketing and PR communications.

Prior to working with Retrogenix, Elizabeth spent five years at PBPK modelling and simulation company, Simcyp – one of the UK’s most successful university spinouts which exited in a $32 million trade sale to Certara in 2012.

Elizabeth has a PhD in molecular biology from the University of Manchester, UK.